RxDoctor Payments Data

Christopher Zylak, MD

Vascular & Interventional Radiology · Spokane, WANPI 1669435905

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (32.0%), speaking fees and royalties or licence payments — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Medtronic at 34.1% of the total. Reporting peaked in 2024 at $16,650 and has fallen 76.9% since, to $3,842 in 2025. Among vascular & interventional radiology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,376in general payments, 2019–2025

Across 269 payments — averaging $161.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$15K
  • Johnson & Johnson$14K
  • Balt USA, LLC$3K
  • Microvention, Inc.$1K
  • Sirtex Medical Inc$1K
  • Route 92 Medical, Inc.$1K
  • plus $7K from 27 others
$12,371in research payments, 2019–2025

Across 12 payments — averaging $1030.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$12K

What the payments were for

  • Royalty or licence$11,24726%
  • Consulting fees$3,7509%
  • Speaking & faculty fees$12,65529%
  • Travel & lodging$1,6364%
  • Food & beverage$13,88332%
  • Education$2050%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,376 in reported general payments places this provider in the 90th percentile of 110 vascular & interventional radiology providers in Washington.

See all vascular & interventional radiology providers in Washington

Medicare billing

Part B allowed, 2024
$218,641
Medicare patients
862
Services billed
2,900

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Spokane

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →